DK0427518T3 - NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse - Google Patents

NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse

Info

Publication number
DK0427518T3
DK0427518T3 DK90312147.3T DK90312147T DK0427518T3 DK 0427518 T3 DK0427518 T3 DK 0427518T3 DK 90312147 T DK90312147 T DK 90312147T DK 0427518 T3 DK0427518 T3 DK 0427518T3
Authority
DK
Denmark
Prior art keywords
designates
preparation
chained
straight
branched
Prior art date
Application number
DK90312147.3T
Other languages
Danish (da)
English (en)
Inventor
Yoel Kloog
Jeffery J Feigenbaum
Raphael Mechoulam
Mordechai Sokolowsky
Simon Benita
Original Assignee
Yissum Res Dev Co
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Univ Ramot filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of DK0427518T3 publication Critical patent/DK0427518T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK90312147.3T 1989-11-07 1990-11-06 NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse DK0427518T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Publications (1)

Publication Number Publication Date
DK0427518T3 true DK0427518T3 (da) 1995-07-24

Family

ID=11060554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312147.3T DK0427518T3 (da) 1989-11-07 1990-11-06 NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse

Country Status (11)

Country Link
EP (1) EP0427518B1 (de)
JP (1) JPH0768235B2 (de)
KR (1) KR950005914B1 (de)
AT (1) ATE119898T1 (de)
AU (1) AU631262B2 (de)
CA (1) CA2029419C (de)
DE (1) DE69017839T2 (de)
DK (1) DK0427518T3 (de)
ES (1) ES2071786T3 (de)
IL (1) IL92238A (de)
ZA (1) ZA908914B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
IL132784A (en) * 1997-05-07 2004-07-25 Unimed Pharmaceutical Inc Pharmaceutical compositions containing dronabinol
JP2002512188A (ja) * 1998-04-21 2002-04-23 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗酸化剤及び神経保護剤としてのカンナビノイド類
EP1928853A4 (de) 2005-09-29 2011-02-16 Amr Technology Inc Verfahren zur herstellung von delta-9-tetrahydrocannabinol
DE102015112092B4 (de) 2015-07-24 2022-03-10 Beko Technologies Gmbh Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR910009687A (ko) 1991-06-28
CA2029419C (en) 2004-05-25
IL92238A (en) 1995-07-31
KR950005914B1 (ko) 1995-06-07
AU631262B2 (en) 1992-11-19
DE69017839T2 (de) 1995-08-31
JPH03209377A (ja) 1991-09-12
ZA908914B (en) 1991-09-25
DE69017839D1 (de) 1995-04-20
EP0427518B1 (de) 1995-03-15
IL92238A0 (de) 1990-07-26
JPH0768235B2 (ja) 1995-07-26
ATE119898T1 (de) 1995-04-15
EP0427518A1 (de) 1991-05-15
CA2029419A1 (en) 1991-05-08
ES2071786T3 (es) 1995-07-01
AU6583490A (en) 1991-05-30

Similar Documents

Publication Publication Date Title
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
DE69012840D1 (de) Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben.
GR3004902T3 (de)
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
PH25859A (en) Composition for treatment of ischemic disorder
IL84917A (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
ES2046641T3 (es) Composicion antitumoral.
TW218016B (de)
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
MX9206930A (es) Nuevos compuestos
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
IL95619A0 (en) N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
DE68923231D1 (de) Antihypertensive 3-Piperidinylindazol-Derivate.
DE69405999T2 (de) Pharmazeutisch wirksame enantiomere
TW275629B (de)
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.